Last update 29 Apr 2025

ADT-030

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ADT 030, ADT030
Target
CTNNB x PDE10A x RAS
Action
inhibitors
Mechanism
CTNNB inhibitors(Beta catenins inhibitors), PDE10A inhibitors(Phosphodiesterase 10A inhibitors), RAS inhibitors(RAS type GTPase family inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Colonic CancerLung CancerPancreatic Cancer+ [1]
Inactive Indication-
Originator Organization
ADT Pharmaceuticals
Active Organization
Augusta UniversityAugusta UniversityThe University of Alabama at BirminghamThe University of Alabama at BirminghamAuburn UniversityAuburn University
+ [1]
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with ADT-030
Login to view more data
100 Translational Medicine associated with ADT-030
Login to view more data
100 Patents (Medical) associated with ADT-030
Login to view more data
100 Deals associated with ADT-030
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colonic CancerPreclinical
United States
Augusta UniversityAugusta University
29 Apr 2025
Colonic CancerPreclinical
United States
Auburn UniversityAuburn University
29 Apr 2025
Colonic CancerPreclinical
United Kingdom
The University of Alabama at BirminghamThe University of Alabama at Birmingham
29 Apr 2025
Pancreatic CancerPreclinical
United States
Augusta UniversityAugusta University
29 Apr 2025
Pancreatic CancerPreclinical
United States
Auburn UniversityAuburn University
29 Apr 2025
Pancreatic CancerPreclinical
United Kingdom
The University of Alabama at BirminghamThe University of Alabama at Birmingham
29 Apr 2025
Lung CancerPreclinical
United States
Augusta UniversityAugusta University
29 Apr 2025
Lung CancerPreclinical
United States
Auburn UniversityAuburn University
29 Apr 2025
Lung CancerPreclinical
United Kingdom
The University of Alabama at BirminghamThe University of Alabama at Birmingham
29 Apr 2025
Breast CancerPreclinical
United States
Auburn UniversityAuburn University
21 Jun 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free